These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33121321)

  • 41. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
    Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
    Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
    Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
    Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost.
    Liu H; Wang H; Yang W; Cheng Y
    J Am Chem Soc; 2012 Oct; 134(42):17680-7. PubMed ID: 23050493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells.
    Zhou Y; Li J; Lu F; Deng J; Zhang J; Fang P; Peng X; Zhou SF
    Drug Des Devel Ther; 2015; 9():2635-45. PubMed ID: 25999697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation.
    Kulhari H; Pooja D; Singh MK; Chauhan AS
    Drug Dev Ind Pharm; 2015 Feb; 41(2):232-8. PubMed ID: 24237325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
    Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
    Kitchens KM; El-Sayed ME; Ghandehari H
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy.
    Fatani WK; Aleanizy FS; Alqahtani FY; Alanazi MM; Aldossari AA; Shakeel F; Haq N; Abdelhady H; Alkahtani HM; Alsarra IA
    Molecules; 2023 May; 28(9):. PubMed ID: 37175381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
    Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
    Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? In the search for minimizing of the adverse effects of PAMAM administration.
    Labieniec-Watala M; Przygodzki T; Sebekova K; Watala C
    Int J Pharm; 2014 Apr; 464(1-2):152-67. PubMed ID: 24463003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review.
    Fana M; Gallien J; Srinageshwar B; Dunbar GL; Rossignol J
    Int J Nanomedicine; 2020; 15():2789-2808. PubMed ID: 32368055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposomes for effective drug delivery to the ocular posterior chamber.
    Lai S; Wei Y; Wu Q; Zhou K; Liu T; Zhang Y; Jiang N; Xiao W; Chen J; Liu Q; Yu Y
    J Nanobiotechnology; 2019 May; 17(1):64. PubMed ID: 31084611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
    Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Charge affects the oral toxicity of poly(amidoamine) dendrimers.
    Thiagarajan G; Greish K; Ghandehari H
    Eur J Pharm Biopharm; 2013 Jun; 84(2):330-4. PubMed ID: 23419816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.
    Sadekar S; Ghandehari H
    Adv Drug Deliv Rev; 2012 May; 64(6):571-88. PubMed ID: 21983078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro dose-response effects of poly(amidoamine) dendrimers [amino-terminated and surface-modified with N-(2-hydroxydodecyl) groups] and quantitative determination by a liquid chromatography-hybrid quadrupole/time-of-flight mass spectrometry based method.
    Hernando MD; Rosenkranz P; Ulaszewska MM; Fernández-Cruz ML; Fernández-Alba AR; Navas JM
    Anal Bioanal Chem; 2012 Nov; 404(9):2749-63. PubMed ID: 22875538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of efficient gene delivery systems by grafting pegylated alkylcarboxylate chains to PAMAM dendrimers: Evaluation of transfection efficiency and cytotoxicity in cancerous and mesenchymal stem cells.
    Ayatollahi S; Hashemi M; Oskuee RK; Salmasi Z; Mokhtarzadeh A; Alibolandi M; Abnous K; Ramezani M
    J Biomater Appl; 2015 Nov; 30(5):632-48. PubMed ID: 26265706
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Wei X; Liu Z; Zhao Z
    Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative anti-inflammatory activity of poly(amidoamine) (PAMAM) dendrimer-dexamethasone conjugates with dexamethasone-liposomes.
    Choksi A; Sarojini KV; Vadnal P; Dias C; Suresh PK; Khandare J
    Int J Pharm; 2013 Jun; 449(1-2):28-36. PubMed ID: 23583708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
    Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
    J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.